Search

Your search keyword '"Cho, Eun Kyung"' showing total 13 results
Start Over Author "Cho, Eun Kyung" Publisher wiley
13 results on '"Cho, Eun Kyung"'

6. Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization

Author

Setlur, Sunita R., primary, Ihm, Chunhwa, additional, Tchinda, Joelle, additional, Shams, Soheil, additional, Werner, Lillian, additional, Cho, Eun Kyung, additional, Thompson, Christina, additional, Phillips, Kimberly, additional, Rassenti, Laura Z., additional, Kipps, Thomas J., additional, Neuberg, Donna, additional, Freedman, Arnold S., additional, Lee, Charles, additional, and Brown, Jennifer R., additional

Published
2010
Full Text
View/download PDF

12. Intensive postoperative surveillance using chest CT and bone scan in patients with locally advanced breast cancer.

Author

Kim YS, Kim EY, Park HK, Ahn HK, Hong J, Cho EK, and Choi HY

Subjects
Breast Neoplasms mortality, Breast Neoplasms pathology, Breast Neoplasms surgery, Female, Humans, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local surgery, Postoperative Period, Radiography, Abdominal, Radiography, Thoracic, Republic of Korea, Retrospective Studies, Sensitivity and Specificity, Tomography, X-Ray Computed, Breast Neoplasms diagnostic imaging, Continuity of Patient Care, Neoplasm Recurrence, Local diagnostic imaging
Published
2014
Full Text
View/download PDF

13. Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.

Author

Park SH, Park YH, Lee JN, Bang SM, Cho EK, Shin DB, and Lee JH

Subjects
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols adverse effects, Capecitabine, Cisplatin adverse effects, Deoxycytidine adverse effects, Deoxycytidine therapeutic use, Epirubicin adverse effects, Female, Fluorouracil analogs & derivatives, Humans, Male, Middle Aged, Treatment Outcome, Adenocarcinoma drug therapy, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Biliary Tract Neoplasms drug therapy, Cisplatin therapeutic use, Deoxycytidine analogs & derivatives, Epirubicin therapeutic use
Abstract

Background: Advanced biliary tract carcinomas (BTCs) are associated with a very poor prognosis. New therapeutic strategies therefore are needed to improve efficacy and survival, and the current study was designed with a new, effective drug combination., Methods: Patients with recurrent or metastatic BTC received a combination of epirubicin at a dose of 50 mg/m(2), cisplatin at a dose of 60 mg/m(2) on Day 1, and capecitabine at a dose of 1000 mg/m(2) twice daily for 2 weeks. Treatment was repeated every 3 weeks., Results: A total of 43 patients (22 with extrahepatic cholangiocarcinoma, 15 with intrahepatic cholangiocarcinoma, and 6 with gallbladder carcinoma) were treated. The median age was 53 years (range, 36-69 yrs) and 5 patients had a Zubrod performance status of 2. Seventeen patients achieved a partial response (40%; 95% confidence interval [95% CI], 21-49%) and 10 had stable disease. With a follow-up duration of 18 months, the median survival time was 8 months (95% CI, 6-10 mos). In total, 187 chemotherapy cycles were delivered, with a median of 5 cycles per patient (range, 1-9 cycles). Toxicity was mainly myelosuppression and mucositis, but no patients died of toxicity., Conclusions: This combination chemotherapy with epirubicin, cisplatin, and capecitabine offered promising antitumor activity in patients with advanced BTC.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results